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Abstract
Parkinson’s disease (PD) is the most common motor neurodegenerative disorder. Olfactory dysfunction is a prevalent
feature of PD. It often precedes motor symptoms by several years and is used in assisting PD diagnosis. However, the
cellular and molecular bases of olfactory dysfunction in PD are not known. The fruit fly Drosophila melanogaster, expressing
human alpha-synuclein protein or its mutant, A30P, captures several hallmarks of PD and has been successfully used to
model PD in numerous studies. First, we report olfactory deficits in fly expressing A30P (A30P), showing deficits in two out
of three olfactory modalities, tested – olfactory acuity and odor discrimination. The remaining third modality is odor
identification/naming. Second, oxidative stress is an important environmental risk factor of PD. We show that oxidative
stress exacerbated the two affected olfactory modalities in younger A30P flies. Third, different olfactory receptor neurons
are activated differentially by different odors in flies. In a separate experiment, we show that the odor discrimination deficit
in A30P flies is general and not restricted to a specific class of chemical structure. Lastly, by restricting A30P expression to
dopamine, serotonin or olfactory receptor neurons, we show that A30P expression in dopamine neurons is necessary for
development of both acuity and discrimination deficits, while serotonin and olfactory receptor neurons appeared not
involved. Our data demonstrate olfactory deficits in a synuclein fly PD model for exploring olfactory pathology and
physiology, and for monitoring PD progression and treatment.
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Introduction
Parkinson’s disease (PD) is a motor degenerative disease,
preferentially affecting the dopamine system. It is characterized
by cardinal symptoms of bradykinesia, rigidity, tremor and
postural instability. Olfactory impairments in PD were first
documented in 1975 [1] and were considered the earliest symptom
in the premotor phase of PD, Braak stage 1 [2]. The olfactory
impairments can precede the appearance of motor symptoms by
years [3]. Indeed, Lewy bodies (LBs) appear first in the olfactory
bulb, before spreading to nuclei in brain stem, in amygdala (Stage
2–3) and then spreading into substantia nigra and other regions of
the midbrain (stage 4: clinical disease stage), affecting motor
functions.
Olfactory impairments in PD patients are prevalent, affecting
80 to 90% of both idiopathic PD patients and familial
parkinsonism [4–6]. They comprise deficits in all three functional
domains: odor threshold (acuity), identification and discrimination
[7–9]. These deficits were shown to predate the onset of motor
symptoms by years, particularly for relatives of patients diagnosed
with PD [3,10,11]. Therapeutic intervention is best to be
administrated early during disease progress, prior to significant
neurodegeneration. For this reason, early diagnosis and differential
diagnosis of PD from other motor disorders, such as vascular
parkinsonism, Methylphenyltetrahydropyridine-induced parkin-
sonism, progressive supranuclear palsy (PSP) and corticobasal
degeneration (CBD), are important and can be facilitated by
assessing olfactory functions [9,12–14].
Sporadic cases of PD predominate over heritable ones, and
environmental factors such as oxidative stress appear to be
involved [15–17]. Indeed, chronic administration of the herbicide
paraquat (PQ) alone causes selective loss of nigral dopamine
neurons with a concomitant emergence of motor deficits [18–20]
and is used as a toxic PD model.
High expression of human a-synuclein (aSyn) directly contrib-
utes to PD pathology. Triplication, duplication and point
mutations in aSyn are associated with dominantly inherited PD
[21,22]. Allele of synuclein A30P (A30P) is linked to early onset
familiar PD. Together with other PD-associated genes, aSyn and
A30P transgenic flies were made to model Parkinson’s disease
[23]. When A30P is expressed in all neurons, flies show classic
hallmarks of PD: the formation of Lewy body-like inclusions in
aged animals, progressive and selective loss of dopaminergic
neurons and progressive development of motor deficits, which is
responsive to L-DOPA treatment [24–28].
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In the present study, we examined the motor function in a pre-
established A30P fly Parkinson’s disease model. Using A30P flies,
we asked whether A30P synuclein flies would develop olfactory
impairments. Then, we examined the chronological relationship
between the occurrences of olfactory and motor impairments.
Separately, we determined whether the olfactory modality of order
acuity (OA), odor discrimination (OD) or both, were affected in
A30P flies, using T-maze assays [29]. Then, we investigated
whether the functions of OA and OD were sensitive to oxidative
stress, and whether the OD impairment was odor-specific or non-
specific.
Results
Aged A30P Flies Show Deficit of Climbing
To verify A30P protein expression in a pre-established A30P
PD fly model, we used immunoblotting and showed that A30P
protein was expressed in the heads of A30P flies, carrying both a
pan-neural Elav-gal4 driver and an UAS-A30P transgene, but not
in Control (CT) flies that carried only UAS-A30P transgenes
(Figure 1A). To verify reported motor deficit in A30P flies [25], we
next examined the climbing performance of A30P flies, using
Countercurrent apparatus. Countercurrent apparatus allowed us
to monitor the climbing ability through multiple climbing trials in
a test (Figure 1B). Details on the climbing assay can be found in
the Methods section. We found a lower percentage of A30P flies
reaching the far right fifth and sixth tube, receiving a score of 4
and 5, respectively, while a higher percentage of A30P flies
(59.98%) was retained in the first tube after five trials, receiving a
score of zero (**P,0.01; Figure 1C, left). A compounded climbing
performance index (PI) based on fly distribution between 6 tubes
showed 64% decrease of PI in 15 days old A30P (**P=0.0014,
Figure 1C, right), validating that A30P flies exhibit impaired
motor function.
A30P Flies Show Age-accelerated Deficits in Odor Acuity
and Odor Discrimination
We asked whether A30P expression would affect olfactory
function in Drosophila. Olfactory functions comprised three major
domains: odor acuity, odor discrimination and odor identification.
Odor acuity (OA) and odor discrimination (OD) assays were
performed using fly T-maze [29], allowing flies to make a
spontaneous choice between an odor versus air in OA assay or
between a mix of foreground and background odors versus a
background odor alone in the OD assay (Figure 2) [30]. Detailed
description of both assays can be found in figure legend and the
methods section.
Olfaction is a sensory function that declines with age [31–34].
In OA assay, we measured flies’ ability to detect sub-threshold
concentrations of benzaldehyde (BA). We found A30P flies as
young as three-days old showed olfactory impairment in detecting
0.05% BA, and such impairment progressed to inability to sense
0.1% BA on day five and fifteen (Figure 3A).
In OD assay, we measured flies’ ability to discriminate between
1.5% BA from a background odor of 15% of 4-methyl-
cyclohexanol (MCH). The concentrations of both odors used in
OD assay were at a bioequivalent concentrations, meaning that
while 1.5% BA and 15% MCH were presented at the opposite
ended of a T-maze, flies would show equal preference for 1.5% BA
and 15% MCH, by distributing 50:50 at the two T-maze ends
[30]. Also, 15% of MCH was pre-determined to induce a
saturated behavior response, meaning that higher than 15% of
MCH would not produce a higher score [30]. As a result, flies that
failed to discriminate BA from MCH would not produce a higher
behavior score by misrecognizing BA+15% MCH side containing
higher than 15% of MCH. The odor discrimination function
appears to initially improve with age in control animals (CT) and
starts to show impairment on day five in A30P flies (Figure 3B).
Both OA and OD impairments in A30P flies manifested on day
five, when the animals still retained normal motor function,
suggesting olfactory deficits preceded motor function decline
(Figure 3A–C).
Age-dependent pathologies are a key feature of degenerative
diseases. To determine whether aging would exacerbate OA and
OD deficits, we calculated the PIA30P/PICT ratios in 5 and 10 day
old flies. The OA and OD ratios significantly decreased on day 10,
compared with day 5. OA decreased 16.31% (***P= 0.0004), and
OD decreased 23.25% (*P= 0.024; Figure 3D), suggesting aging
worsened both olfactory deficits.
Odor Acuity and Discrimination are Sensitive to Oxidative
Stress
Oxidative stress has been linked to Parkinson’s disease by both
post-mortem pathological [35–37] and by epidemiological studies
[38,39]. Paraquat (PQ: N,N9-dimethyl-4,49-bipyridinium dichlo-
ride) is one of the most widely used herbicides, and was shown to
induce selective dopamine cell death in substantial nigra when
systematically administrated in rodent PD models [18,19,40]. We
asked whether olfactory acuity and discrimination of A30P flies
could be affected by oxidative stress. To do so, we fed newly
enclosed adult flies with 5 mM PQ mixed into food for the
duration of the experiment, and tested OA and OD performances
in the animals. Five day old A30P flies showed healthy OA
function in detecting 0.05% BA and mild OD impairment
(*P=0.0329). The 0.05% BA used in the PQ OA assay, which
was lower than what was used in the OA assay on day5 in
Figure 3A, is more challenging. In the PQ OD assay, the same
odor pair and concentrations of odors as in Figure 3B were used.
We found PQ feeding significantly enhanced both OA and OD
deficits in A30P, compared to CT (***P,0.001, Figure 4 A and
B), suggesting oxidative stress worsened both olfactory deficits.
Aged A30P Flies Exhibited Non-odor-specific
Discrimination Deficit
Drosophila has a diverse family of odorant receptor (Or) genes.
Expression of each Or is restricted to a subset of the olfactory
receptor neurons (ORNs) that project to the same glomerulus in
the antennal lobe, a mammalian olfactory bulb analog, where
odor information is first encoded [41,42]. Studies show that
quality, quantity and duration of odor exposure activate ORNs in
a specific manner. Aromatic odors often activate fewer ORNs,
compared to most alcohols, which activate a broader range of
ORNs [43].
We asked whether OD deficit seen in A30P fly is restricted to its
ability to discriminate a particular class of odor chemicals. Odor
chemical class specificity would suggest that OD deficit in A30P
flies affects a specific subset of Or-expressing neurons. We chose a
panel of five odors: BA, Methyl Salicylate (MS), 1-Propanol (1-
Pro), ethyl acetate (EA), Butyl acetate (ButA), and ethyl hexanoate
(EH) to represent three classes of chemical structures: aromatics,
alcohol, or esters. Together, the five odorants can activate or
inhibit 23 out of the 24 types of functional Or-expressing neurons
[43]. We found fifteen day old A30P flies showed non-odor specific
discrimination deficit (Figure 5), suggesting that deficit in the odor
discrimination is not likely mediated by impairment of any
particular ORN type.
Olfactory Deficits of A30P Flies
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Odor Acuity and Discrimination Deficits in A30P Aged
Flies are Dopaminergic
Dopamine neurons are selectively more susceptible to the
toxicity of synuclein and A30P overexpression [44,45]. We asked
whether OA and OD deficits in A30P flies were due to: (a)
functional impairments of dopamine neurons in olfaction trans-
mission, and/or (b) functional impairments of ORNs. To answer
(a), we restricted A30P expression to dopamine neurons, using
tyrosine hydroxylase (TH)-gal 4 driver. TH is an enzyme required
to convert L-tyrosine into L-DOPA, a precursor to making
dopamine. In comparison, we restricted A30P expression to
cholinergic neurons, using Cha (choline acetyltransferase)-gal4
driver. Cha is an enzyme required to add acetyl-CoA to choline to
produce neurotransmitter acetylcholine. To answer (b), we
restricted A30P expression in ORNs, using Or83b-gal4 driver.
Or83b is an olfactory co-receptor, broadly expressed in all ORNs
to mediate responses to all odors [46]. We measured PIOA and
PIOD of fifteen day old A30P and CT flies.
A30P flies showed OA and OD deficits with Elav-driven A30P
in all neurons (OAElav: ***P= 1.69610
25; ODElav: **P=0.005)
and with TH-driven A30P in only dopamine neurons (OATH:
**P= 0.002; ODTH: **P= 0.006). In contrast, Cha- and Or83b-
driven A30P expression in cholinergic and ORNs, respectively, did
not show OA and OD impairments, compared to CT (OAcha:
P= 0.398; ODcha: P= 0.700; OAOr83b: P= 0.200; ODOr83b:
P= 0.773; Figure 6 A and B). These results suggested that
dopamine neurons were the targets of A30P protein toxicity,
affecting OA and OD performances as seen in Elav-A30P flies.
Discussion
Olfactory deficits and misregulation of synuclein expression are
prevalent in Parkinson’s and Alzheimer’s patients. Prior to our
study, olfactory deficits in a synuclein PD fly model were not
known. Here, through examining olfactory acuity and odor
discrimination, we report impairments in both olfactory domains
in Elav-A30P flies that precede appearance of motor dysfunction
and are accelerated by oxidative stress with paraquat feeding.
Presented with different odor pairs, A30P flies show impairments
in odor discrimination in non odor specific manner, as reported in
PD human patients [47]. Limiting A30P protein expression to
dopamine neurons caused impairments in odor acuity and
discrimination similar to those in flies with Elav-driven A30P in
all neurons, suggesting impairments are mediate by dysfunction in
Figure 1. A30P flies show climbing deficit. (A) A30P expression in A30P flies. A30P protein from heads of five days old flies was probed using
human-specific aSyn antibody. Pan-actin expression was used as an internal control. (B) Climbing assay. Climbing performance was measured based
on negative geotaxis using countercurrent apparatus. By moving the upper five climbing tubes back and forward between each trial per test, flies
would distribute between tubes 0 through 5. Each trial is 10 seconds. Details are in materials and methods. (C) Left: Fly distribution based on climbing
performance. More CT flies reached the No.5 tube, while more A30P flies stayed in the No.1 tube. The percentage distribution (%) for a tube is [(# of
flies in the tube)/(# of flies per test)]6100. The assays were performed with flies of fifteen days old. Fifty to eighty flies were used per trial. Ct vs. A30P:
t0 (8) = 3.588, **P0 = 0.007; t4(8) = 3.770, **P4 = 0.0054; t5(8) = 3.846, **P5 = 0.0049. Right: The compounded climbing performance index (PI) from the
left. PI = 100%6[S5i = (# of flies)i6i/(# of flies per test)65]. t(8) = 4.768, **P= 0.0014; CT is +/+: A30P/+; A30P is Elav/+: A30P/+, hereafter unless noted
otherwise. Student t-test.
doi:10.1371/journal.pone.0097758.g001
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dopamine neurons. Consistent with our observations, mice
expressing wild-type human synuclein, driven by Thy1 promoter,
show deficits in both odor acuity and discrimination, tested by
buried pellet and block assays [48]. Odor acuity was also impaired
in transgenic rats, expressing both A30P and A53T synuclein
under TH promoter, prior to appearance of motor symptoms [49],
suggesting a direct involvement of dopamine neurons, as this study
also indicated.
Olfactory organization is conserved between mammals and
insects: axons of olfactory receptor (sensory) neurons are wired and
converged based on the type of odorant receptor (Or) expressed.
Projection axons are organized into distinctive spherical neuropils,
or glomeruli, in the antennal lobe (AL) in Drosophila or the olfactory
blub (OB) in mammals, respectively [50].
Whether deterioration of olfactory function is associated with
central dopamine deficiency is continuously debated. Olfactory
dysfunction in PD patients was thought to plateau without further
deterioration to reflect disease progression [47]. However, careful
sample selection, closer follow-up and an improved mechanistic
understanding have been proposed to reveal the progression
olfactory impairments with disease advancement [51]. Common
complications are an aging-dependent natural decline in olfactory
function and compensatory responses. A30P PD flies provide an
excellent model to study the dynamics of olfactory deficits and
other PD-related pathologies. Compared to mouse and rat models,
flies have a much shorter lifespan and faster disease progression.
Olfactory deficits can be detected in as early as five day old adults
before motor deficit becomes apparent in 15 day old flies. A fly PD
model allows studies with large animal populations to test an array
of odor concentrations for different age groups, needed in
olfactory studies, and provides the necessary statistical power to
draw conclusions.
Whether olfactory deficits in PD originate from sensory, central
or motor neuron deficits is not known and is difficult to disentangle
in human or mouse studies. Spontaneous, in contrast with
conditioned and experience-dependent [52], odor detection and
discrimination were proposed to be processed locally within the
antennal lobe in insects [53,54] and the olfactory bulb in mammals
[55–60]. Results of OA and OD assays in this study depend on
spontaneous responses and, thus, argue against involvement of the
central nerve system. Known odor receptor neurons (ORNs) are
mostly glutaminergic [61,62] and acetylcholinergic (ACh) [63,64].
At the same time, dopamine neurons were found to innervate the
center of neurpiles and in the glial layer at intraglomeruli [65],
indirectly modulating the outputs of olfactory sensory neurons in
flies. Therefore, normal OA and OD function of Or83b-A30P flies
and olfactory deficits seen in TH-A30P flies together suggest that
olfactory deficits in A30P flies were not due to dysfunction of
ORNs but due to local dopamine neurons modulating ORNs in
the antennal lobe. A direct involvement of local antenna lobe
neurons in olfactory perception was also supported by a recently
study, which showed reduced neural activity in electroantenno-
gram and reduced marker for neuronal active zones in PINK null
flies [66] - a transgenic fly with autosomal recessive PD.
Figure 2. Fly odor acuity (OA) and odor discrimination (OD) assays. Fly odor acuity (OA) and odor discrimination (OD) were tested using T-
maze apparatus. Flies loaded into T-maze were dropped to a choice point between [BA] and air in the odor acuity assay or between [BA]e and
[MCH]e+[BA]e in the odor discrimination assay. To avoid an inherent directional reference in assays, an odor of a pair was delivered from one end of T-
maze during the first trial (PI1) and from the opposite end during the second trial (PI2). A test comprised two trials. The performance index (PI) of a
test is the average of PI1 and PI2. When the equilibrium concentrations of BA ([BA]
e) and MCH ([MCH]e) were delivered from the opposite ends of T-
maze, flies would show no preference for either [BA]e or [MCH]e by equally distributing between the two end-tubes. Flies with health odor
discrimination would detect the presence of [BA]e, a foreground odor, in the background of [MCH] e and run to [MCH]e tube, avoiding the [MCH]e+
[BA]e tube. The formula for PI calculation was expressed as a percentage of the absolute number of flies that were differentially distributed between
two end-tubes, divided by the total number of flies in a trial. PI1 or 2 = 100%6|(# of L)- (# of R)|/(# of total flies in a test).
doi:10.1371/journal.pone.0097758.g002
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Figure 3. A30P flies show age-accelerated deficit in odor acuity and odor discrimination. (A) A30P flies showed decreased odor acuity (d3:
t(6) = 2.916, *P=0.0268; d5: t(10) = 3.982, **P= 0.0026; d15: t(5) = 4.046, **P= 0.0099). Odors used are 0.05% BA vs. air on day3 and 0.1% BA versus air
on day5 and day 10. (B) Aged A30P flies showed decreased performance in odor discrimination (d3: t(8) = 2.094, *P= 0.0695; d5: t(14) = 3.058,
**P= 0.0085; d15: t(6) = 5.915, **P=0.0010). Odor options were 1.5% BA made in 15% MCH background and 15% MCH. (C) A30P flies showed normal
climbing on day 5 (t(14) = 0.7625, P= 0.480). (A–C) Olfactory deficits preceded motor deficit. (D) Aging exacerbated both OA and OD deficits in A30P
flies. The PIs for OA and OD were presented as ratios of PIA30P over PICT. Odors used in OA assays were 0.1% BA and air. Odors used in OD assays were
the same as in Figure 2B. OA ratio: t(14) = 4.563, ***P=0.0004; OD ratio: t(7) = 2.680, *P=0.0316, Student t-test.
doi:10.1371/journal.pone.0097758.g003
Figure 4. Oxidative stress exacerbated olfactory deficits in A30P flies. (A) Odor acuity (OA) and (B) odor discrimination (OD) assays. Five-
days old A30P flies showed normal olfactory acuity (0.05% BA vs. air) and mild discrimination deficit. Paraquat (PQ) feeding enhanced OA and OD
deficits in A30P (For CT+PQ vs. A30P+PQ comparison: FOA1,12 = 6.243, *P= 0.0280; FOD1,23 = 5.5152, *P= 0.0329). In OA assays, the mean differences
of CT vs. CT+PQ was 10.04% (n.s.: P.0.05) and of A30P vs. A30P+PQ was 27.96% (***P,0.001). In OD assays, the mean differences of CT vs. CT+PQ was
5.97% (n.s.: P.0.05) and of A30P vs. A30P+PQ was 16.25% (***P,0.001). A30P and PQ-feeding were variables significantly interacting with each other
(Interaction: *POA = 0.028, *POD= 0.033), suggesting an enhancement effect. PQ was 5 mM; wt was an internal control for apparatus assays. Odors
used in OA were 0.05%BA and air. Odors used in OD assays were the same as in Figure 3B. Other comparisons: ***P,0.001, **P,0.01, *P,0.05, ns:
non significant. Two-way ANOVA followed by Tukey Post-hoc tests among CTs and A30Ps with or without PQ-feeding.
doi:10.1371/journal.pone.0097758.g004
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Deficit in motor neurons was proposed to contribute olfactory
impairments in PD patients. PD patients showed significantly
decreased sniff airflow and volume. When asked to sniff vigorously,
patients’ performances in odor acuity and identification improved
[67]. Indeed, active sensing by sniffing (inhaling air into the nasal
cavity) is the first step and a requirement for normal olfactory
function for human and rodents. It is therefore difficult to
disassociate the prime cause of olfactory deficits between the
dysfunctions of motor or sensory neurons. On the contrary, flies
sample odorants in air directly through odor sensory neurons that
reside in the sensillum, and do not require motor function, such as
sniffing. Therefore, olfactory deficits in A30P flies support direct
involvement of sensory impairment, specifically, mis-modulation
of sensory neuron output by A30P expression in dopamine
neurons. This is also consistent with observations that increased
sniffing effort in PD patients does not restore olfactory function
back to normal and is only beneficial to the worst performers that
tend to show greatest motor dysfunction [67].
Constitutive neurogenesis in OB is an active event, where
activity is highly responsive to injuries. Inhibition of neurogenesis
in OB leads to olfactory impairments [68]. Both increase and
decrease of neurogenesis in olfactory bulbs were reported
Parkinson’s patients and PD animal models [49,69–73]. The
discrepancies may be due to the time points when neurogenesis
was examined: early or late during PD progression. Possible
compensation mechanism that leads to upregulated neurogenesis
was proposed to explain the increased neurogenesis in OB in PD
patients. In transgenic PD models, the discrepancies may be also
Figure 5. A30P flies showed non-odor-specific discrimination deficits. Fifteen-days old flies were tested for the ability to discriminate the
presence of different odors made in 15% MCH versus 15% MCH alone. Chemical structures of each odor are shown and arranged from aromatics on
the left, to esters on the right, based on structure similarity to MCH, the background odor. Behavior-equivalent concentrations used were 1.5% of BAe,
20% MSe, 1% of 1-Proe, 20% of EAe, 10% of ButAe and 5% of EHe made in 15% of MCHe. BA: benzaldehyde, MS: methyl salicylate, 1-Pro: 1-propanol,
EA: ethyl acetate, ButA: butyl acetate, EH: ethyl hexanoate. For CT vs. A30P comparisons from left to right, tBA(6) = 5.915,**P= 0.001, tMS(7) = 2.,*P= , t1-
Pro(6) = 8.986, ***P= 0.0001, tEA(8) = 3.651,**P=0.0065, tButA(12) = 4.750,***P= 0.0005, and tEH(11) = 8.404,***P,0.0001; Student t-test.
doi:10.1371/journal.pone.0097758.g005
Figure 6. A30P expression in dopaminergic neurons causes odor acuity and discrimination deficits in aged A30P flies. Fifteen-days
old A30P flies expressing A30P under Elav-gal4 (Elav), TH-gal4 (TH), Cha-gal4 (Cha) or Or83b-gal4 (Or83b) drivers were tested for odor acuity (A) and
the performance of odor discrimination (B). Young wild-type flies of 1–2 days old were used as internal assay control. Only A30P expressed in
dopamine neurons, A30PTH, showed olfactory acuity and discrimination deficits as seen in A30PElav. The corresponding controls for each comparison
were CTElav (Elav/+; +/+; +/+), CTTH (+/+; +/+; TH/+), CTCha (+/+; +/+; Cha/+), and CTOr83b (Or83b/+; +/+; +/+). OA: tElav(14) = 6.388, ***P,0.0001,
tTH(14) = 3.773, **P=0.0021; OD: tElav(14) = 3.338, **P=0.0049, tTH(14) = 3.257, **P=0.0057; Student t-test.
doi:10.1371/journal.pone.0097758.g006
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due to methods of expressing synculein or its mutant genes: acute
expression by using a conditional system or constitutive expression
by using a promoter. The kinetics of synuclein protein expression
may affect regulation of neurogenesis. In flies, one prominent site
of adult neurogenesis in Drosophila brain is at the conjunction
between antennal lobes and antennal nerve bundle [74]. Extensive
genetic tools available in flies allow to resolve discrepancies and to
investigate the role of neurogenesis in PD pathology and in
olfactory function to determine whether altered neurogenesis is a
primary or secondary effect of olfaction impairments in s synuclein
fly model. By comparing conditional and continuous methods of
expressing synuclein in the same genetic background, Drosophila
PD model can help delineate the effect of synuclein on
neurogenesis.
Materials and Methods
Flies
We used wild-type 2U flies, a pan-neural Elav-gal4 (Elav)
promoter, dopaminergic specific Th-gal4 (TH) promoter, olfacto-
ry-neuron Or83b-gal4 (Or83b) promoter, cholinergic neuron
Cha-gal4 (Cha) promoter from Bloomington Fly center, and a
UAS-human aSyn A30P (A30P) from Mel B. Feany Lab. All flies
were outcrossed to 2U for six or more generations to equilibrate
genetic background before experiments. Flies were raised under a
12:12 light:dark cycle at 25uC and 70% humidity incubator. PQ
was administrated by rearing adult flies in vials with regular food
[75] mixed with PQ. PQ food was made by completely melting the
regular fly food and allowing it to cool at 57u before adding PQ.
PQ-containing fly food was stored up to ten days at 4uC before
usage.
Climbing Assay
Startle-induced negative geotactic climbing was used to measure
climbing performance with a countercurrent apparatus [76].
During testing, a group of 20–30 flies was placed into the far left
‘‘bottom’’ tube at the loading position. Flies were gently tapped
down to the bottom of tube three times with a force of about 1 to
1.5 kg at the frequency of one tap per second. The top ‘‘receiver’’
tubes were quickly moved to the left, allowing flies 10 seconds to
climb up into the top receiver tube at a starting position in each
trial. Flies that succeeded in climbing up to the receiver tube were
transferred to the next bottom tube at the end of the 10 second
period by moving the array of top tubes one slot to the right,
followed by gentle tapping and prompt placement of top tubes
back to the starting position. These steps repeated five times,
providing flies five trials to climb into the top tube. At the end of
the test, flies in the far right bottom tube that successfully climbed
to the top receiver tube in all five trials received a score of 5. Flies
that remained in the first bottom tube at the end of five trials failed
to climb above a tube’s length in each trial and received a score of
0. A Performance index (PI) was calculated as shown in Figure 1
legend.
Olfactory Assays
Flies were collected and kept in clean bottles for one day before
testing. Groups of 50 to 80 flies were transferred into fresh food
vials on the test day. All odors were made fresh in mineral oil using
odor free glass vials. To eliminate odor and any asymmetric biases
in the testing machines, one group of flies was tested with a given
odor (or odor mixture) delivered into the left arm of the T-maze
(PI1), and a second reciprocal group was tested with the same odor
(or odor mixture) delivered into the right arm (PI2). The average of
two performance indices (PIs) from these two groups of flies was
defined as a score for n = 1. Two olfactory assays performed were
odor acuity (OA) and odor discrimination (OD). In the odor acuity
(OA) assay, different concentrations of benzaldehyde (BA) were
paired with odor-free mineral oil (air). Normally, flies can detect
the presence of BA at a very low concentration [77] and show
preference towards or away from BA, depending on BA
concentration. Flies with OA deficits exhibit a higher threshold
of detecting the presence of BA odor and a shifted olfactory
response to BA concentration. In odor discrimination (OD) assay,
flies were tested for ability to detect the presence of a behavior-
equivalent concentration of BA (BAe) odor in the background of
methylcyclohexanol (MCHe) odor versus MCHe odor alone. The
behavior-equivalent concentrations of two odors are those that
produce a PI score close to zero in flies presented with the two
choices at the opposite arms of a T-maze [30]. A zero score means
that flies would show no odor preference and distribute 50/50 in
both arms. Normal flies can identify the presence of BA in the
background of MCH and avoid the arm filled with MCHe and
BAe odor mixture. However, flies with an OD deficit, would show
difficulties in detecting BAe in MCHe background, resulting in a
lower PI score, suggesting failure to discriminate the presence of
BAe in a strong MCHe odorant background.
Immunoblotting
Thirty fly heads were homogenized in 150 ul 2x Laemmli
sample buffer (Bio-Rad, Hercules, CA) and centrifuged for 20
minutes at 13,0006g at 4uC. Protein extract from about five heads
was used per lane on SDS PAGE gels for detecting and visualizing
the expression transgene, human aSyn protein. Antibodies used
were human specific anti-aSyn (1:1000, Cell Signaling Technol-
ogy, Inc., Danvers, MA) and a pan-actin antibody (1:1000; Sigma-
Aldrich Corp., St. Louis, MO).
Statistics
Due to the nature of their mathematical derivation, PIs are
distributed normally. Data were subjected to Student t-test, one-
way or two-way ANOVA test, followed by Tukey post-hoc tests.
All data were presented as ‘‘mean 6 SEM’’. All statistics were
analyzed using Prism 6 (GraphPad Software, Inc.).
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